Riesgo de isquemia o hemorragia cerebral                                   Risk of brain ischemia or hemorrhage  

Spivak IE. Oral Anticoagulants and Atrial Fibrillation: An Update for the Clinical Nurse. Medsurg Nurs. 2015 Mar-Apr;24(2):95-100.

Ferguson C, et al. The caregiver role in thromboprophylaxis management in atrial fibrillation: a literature review. Eur J Cardiovasc Nurs. 2015 Apr;14(2):98-107.

Lane DA, Wood K. Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation. Circulation. 2015 Apr 21;131(16):e412-5. doi: 10.1161/CIRCULATIONAHA.114.012808.

Patrick C, Clarke R. Stroke prevention in nonvalvular atrial fibrillation: update on target-specific oral anticoagulants. J Contin Educ Nurs. 2015 Apr;46(4):152-4. doi: 10.3928/00220124-20150320-12.

Cutugno CL. CE: Atrial Fibrillation: Updated Management Guidelines and Nursing Implications. Am J Nurs. 2015 May;115(5):26-38. doi: 10.1097/01.NAJ.0000465028.05223.39.

Gallagher R, Roach K, Sadler L, Belshaw J, Kirkness A, Zhang L, Proctor R, Neubeck L. Who gets stroke prevention? Stroke prevention in atrial fibrillation patients in the inpatient setting. Heart Lung Circ. 2015 May;24(5):488-94. doi: 10.1016/j.hlc.2014.12.010.

Stewart S, Ball J, Horowitz JD, Marwick TH, Mahadevan G, Wong C, AbhayaratnaWP, Chan YK, Esterman A, Thompson DR, Scuffham PA, Carrington MJ. Standard versus

atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial. Lancet. 2015 Feb 28;385(9970):775-84. doi: 10.1016/S0140-6736(14)61992-9.

Lee G, Campbell-Cole C. Recognising and managing atrial fibrillation in the community. Br J Community Nurs. 2014 Sep;19(9):422-6. doi: 10.12968/bjcn.2014.19.9.422.

Ferguson C, Inglis SC, Newton PJ, Middleton S, Macdonald PS, Davidson PM. The  caregiver role in thromboprophylaxis management in atrial fibrillation: a

literature review. Eur J Cardiovasc Nurs. 2015 Apr;14(2):98-107. doi: 10.1177/1474515114547647.

Aryal MR, Ukaigwe A, Pandit A, Karmacharya P, Pradhan R, Mainali NR, Pathak R, Jalota L, Bhandari Y, Donato A. Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation. Am J Cardiol. 2014 Aug 15;114(4):577-82. doi: 10.1016/j.amjcard.2014.05.038.

Reiffel JA. Atrial fibrillation and stroke: epidemiology. Am J Med. 2014 Apr;127(4):e15-6. doi: 10.1016/j.amjmed.2013.06.002.

Maes F, et al. Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation? Clin Interv Aging. 2014 Jul 15;9:1091-9.

Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, Howard G, Kissela BM, Kittner SJ, Lichtman JH, Lisabeth LD, Schwamm LH, Smith EE, Towfighi A; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; Council on Functional Genomics and Translational Biology. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke. 2014 Jan;45(1):315-53. doi:10.1161/01.str.0000437068.30550.cf.

Davis LL. Preventing stroke in patients with atrial fibrillation. Nurse Pract. 2013 Nov 10;38(11):24-31. doi: 10.1097/01.NPR.0000435781.73316.9c.

Ferguson C, Inglis SC, Newton PJ, Middleton S, Macdonald PS, Davidson PM. Atrial fibrillation: stroke prevention in focus. Aust Crit Care. 2014 May;27(2):92-8. doi: 10.1016/j.aucc.2013.08.002.

Ogbonna KC, Clifford KM. Moving beyond warfarin-are we ready? A Review of the efficacy and safety of novel anticoagulant agents compared to warfarin for the management of atrial fibrillation in older adults. J Gerontol Nurs. 2013 Jul;39(7):8-17. doi: 10.3928/00989134-20130605-01.

Witham D. Atrial fibrillation. Nurs Stand. 2013 Apr 10-16;27(32):59.

Berra K. Antithrombotics for stroke prevention in non-valvular atrial fibrillation: an update. Eur J Cardiovasc Nurs. 2014 Feb;13(1):32-40. doi:10.1177/1474515113477957.

Furie KL, Goldstein LB, Albers GW, Khatri P, Neyens R, Turakhia MP, Turan TN, Wood KA; American Heart Association Stroke Council; Council on Quality of Care and Outcomes Research; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Council on Peripheral Vascular Disease. Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012 Dec;43(12):3442-53. doi: 10.1161/STR.0b013e318266722a. Epub 2012 Aug 2. Erratum in: Stroke. 2013 Mar;44(3):e20. Stroke. 2012 Dec;43(12):e181.

Hickey K. Anticoagulation management in clinical practice: preventing stroke  in patients with atrial fibrillation. Heart Lung. 2012 Mar-Apr;41(2):146-56. doi:10.1016/j.hrtlng.2011.07.008.

Frei SP, Burmeister DB, Coil JF. Frequency of serious outcomes in patients with hypertension as a chief complaint in the emergency department. J Am Osteopath Assoc. 2013; 113(9):664-8. doi: 10.7556/jaoa.2013.032.

Ferguson C, Inglis SC, Newton PJ, Middleton S, Macdonald PS, Davidson PM. Atrial fibrillation: Stroke prevention in focus. Aust Crit Care. 2013 Sep 17. pii: S1036-7314(13)00169-0. doi: 10.1016/j.aucc.2013.08.002.

Flemming KD, Allison TG, Covalt JL, Herzig DE, Brown RD. Utility of a post-hospitalization stroke prevention program managed by nurses. Hosp Pract (1995). 2013; 41(3):70-9. doi: 10.3810/hp.2013.08.1070.

Ogbonna KC, Clifford KM. Moving beyond warfarin-are we ready? A Review of the  efficacy and safety of novel anticoagulant agents compared to warfarin for the management of atrial fibrillation in older adults. J Gerontol Nurs. 2013; 39(7):8-17. doi: 10.3928/00989134-20130605-01.

Wan LH, Zhao J, Zhang XP, Deng SF, Li L, He SZ, Ruan HF. Stroke Prevention Knowledge and Prestroke Health Behaviors Among Hypertensive Stroke Patients in Mainland China. J Cardiovasc Nurs. 2013 Feb 5. [Epub ahead of print]

Neidecker M, Patel AA, Nelson WW, Reardon G. Use of warfarin in long-term care: a systematic review. BMC Geriatr. 2012; 12:14.

Ireland S, MacKenzie G, Gould L, Dassinger D, Koper A, LeBlanc K. Nurse case management to improve risk reduction outcomes in a stroke prevention clinic. Can J Neurosci Nurs. 2010;32(4):7-13.

Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al.  Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart AssociatioNAmerican Stroke Association. Stroke. 2011; 42(2):517-84.

Barrere C, Delaney C, Peterson D, Hickey K. Primary Stroke Center education for nurses: improving core measures. J Nurs Adm. 2010; 40(12):515-21.

Kozub E. Community stroke prevention programs: an overview. J Neurosci Nurs. 2010; 42(3):143-9.

Covington CF, King JA, Fennell I, Jones C, Hutchinson C, Evans A. Developing a community-based stroke prevention intervention course in minority communities: the DC Angels Project. J Neurosci Nurs. 2010; 42(3):139-42.

Vaughn S. Factors influencing the participation of middle-aged and older Latin-American women in physical activity: a stroke-prevention behavior. Rehabil Nurs. 2009; 34(1):17-23. 

 

Riesgo de progresión/recurrencia de isquemia o hemorragia cerebral                                                                                           Risk of brain ischemia or hemorrhage recurrence / progression   

Miyamoto N, Tanaka Y, Ueno Y, Kawamura M, Shimada Y, Tanaka R, et al. Demographic, clinical, and radiologic predictors of neurologic deterioration in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2013; 22(3):205-10. doi: 10.1016/j.jstrokecerebrovasdis.2011.07.018.

Kim H, Kim O. The lifestyle modification coaching program for secondary stroke prevention. J Korean Acad Nurs. 2013; 43(3):331-40. doi: 10.4040/jkan.2013.43.3.331.

White CL, Pergola PE, Szychowski JM, Talbert R, Cervantes-Arriaga A, Clark HD, Del Brutto OH, et al. Blood pressure after

recent stroke: baseline findings from the secondary prevention of small subcortical strokes trial. Am J Hypertens. 2013; 26(9):1114-22. doi: 10.1093/ajh/hpt076

Mackenzie G, Ireland S, Moore S, Heinz I, Johnson R, Oczkowski W, Sahlas D. Tailored interventions to improve hypertension management after stroke or TIA--phase II (TIMS II). Can J Neurosci Nurs. 2013;35(1):27-34.

Mooe T, Bergström L, Irewall AL, Ogren J. The NAILED stroke risk factor trial (nurse based age independent intervention to limit evolution of disease after stroke): study protocol for a randomized controlled trial. Trials. 2013; 14:5. doi: 10.1186/1745-6215-14-5.

Paul NL, Koton S, Simoni M, Geraghty OC, Luengo-Fernandez R, Rothwell PM. Feasibility, safety and cost of outpatient management of acute minor ischaemic stroke: a population-based study. J Neurol Neurosurg Psychiatry. 2013; 84(3):356-61. doi: 10.1136/jnnp-2012-303585.

Menard MM, Smith DB, Taormina C. A program to improve secondary stroke prevention: the Colorado Neurological Institute stroke preventing recurrence of thromboembolic events through coordinated treatment program. J Neurosci Nurs. 2011; 43(4):199-204.

Kim CG, Park HA. Development and evaluation of a web-based education program to prevent secondary stroke. J Korean Acad Nurs. 2011; 41(1):47-60.

Anderson JA, Willson P, Peterson NJ, Murphy C, Kent TA. Prototype to practice: Developing and testing a clinical decision support system for secondary stroke prevention in a veterans healthcare facility. Comput Inform Nurs. 2010; 28(6):353-63. 

 

Versión para imprimir Versión para imprimir | Mapa del sitio
© NAAXPOT SLU © ATIC